Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine.Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances.Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implications associated with the COVID-19 pandemic.To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this link  The over USD 6.5 billion (by 2030) financial opportunity within the psychedelic therapeutics market has been analyzed across the following segments:Target Disease IndicationAnxiety and DepressionTraumaPain DisorderSleep related Disorder Origin of Psychedelic SubstanceNaturalSynthetic Type of Psychedelic SubstanceGamma-hydroxybutyrateKetamineMDMAPsilocybin Route of AdministrationOralIntranasalSublingual Key GeographiesNorth AmericaEuropeAsia-Pacific The Global Psychedelic Therapeutics Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: Celon PharmaiX BiopharmaMAPS Public BenefitMindMedJanssen PharmaceuticalsJazz Pharmaceutical Table of Contents  Preface 2.Executive Summary Introduction Market Landscape: Psychedelic Therapeutics Company Profiles Clinical Trial Analysis Clinical Trial Site Analysis Key Opinion Leader (KOL) Analysis   Academic Grants Analysis Partnerships and Collaborations Mergers and Acquisitions Market Forecast and Opportunity Analysis Concluding Remarks Executive Insights  Appendix 1: Tabulated Data  Appendix 2: List of Companies and Organizations To purchase a copy, please visit Contact DetailsGaurav Chaudhary+1 (415) 800 [email protected]   
Roots Analysis has done a detailed study on  “Global Psychedelic Therapeutics Market, 2020-2030”, covering key aspects of the industry and identifying potential future growth opportunities  To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this link   Key Market Insights Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybinThe pipeline features product candidates based on a variety of psychedelic drug classes, which are being investigated for a wide range of target disease indications, and having different routes of administrationFrom a global perspective, this industry is anticipated to evolve significantly over the next few years as federal / regional regulators in different nations are gradually convinced of the clinical significance of this product classSeveral organizations, having realized the untapped opportunity within this emerging segment of psychedelic therapeutics, have awarded grants of over USD 275 million across 500+ instances between 2015-2020Several trials evaluating various psychedelic compounds against a wide range of therapeutic indication have been registered in the recent pastThe growing interest is also reflected in the partnership activity since 2017; a number of different types of deals involving various drug classes have been established across multiple geographiesPresently, North American companies are actively consolidating their indigenous presence through strategic acquisitions; key value drivers behind such deals include both portfolio and geographical expansionA number of eminent scientists from renowned universities have emerged as key opinion leaders in this domain, owing to their active involvement in clinical development efforts related to interventions based on psychedelicsFuture market size, based on revenue reported from the sales of marketed and late stage psychedelic-based therapies, is anticipated to be distributed across different therapeutic areas and key geographical regions For more information, please visit  Table of Contents  PREFACE1.1.Clinical Trial Sites in North America7. Funding Institute Centers: Analysis by Number of Grants9.3.15.Global Psychedelic Therapeutics Market for Synthetic Substances, 2020-203012.5.2.Global Psychedelic Therapeutics Market for Sleep-Related Disorders, 2020-203012.8.2.Interview Transcript: Andrew Chadeayne, Founder & Chief Executive Officer 14.3.                 iX Biopharma14.3.1.
A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.In addition to other elements, the study includes:A detailed assessment of the current market landscape of drug developers engaged in the development of psychedelic therapeutics.Tabulated profiles of prominent psychedelic therapeutics developers.shortlisted on the basis of the number of pipeline products).Detailed profiles of developers of next generation immune checkpoint modulators (shortlisted on the basis having two or more psychedelics-based therapies in phase II clinical studies and above).An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics.A list of key opinion leaders (KOLs) within this domain, and detailed 2×2 matrices to assess the relative experience of key individuals who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field.A detailed analysis of nearly 545 grants that have been awarded to research institutes engaged in psychedelic therapeutics projects, in the period between 2015 and 2020 (till May).An analysis of the partnerships that have been established in the recent past (2017-2020 till May),A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2017-2020.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Target Disease IndicationAnxiety and DepressionTraumaPain DisorderSleep related DisorderOrigin of Psychedelic SubstanceNaturalSyntheticType of Psychedelic SubstanceGamma-hydroxybutyrateKetamineMDMAPsilocybinRoute of AdministrationOralIntranasalSublingualKey GeographiesNorth AmericaEuropeAsia-PacificTranscripts of interviews held with the following senior level representatives of stakeholder companiesAndrew Chadeayne (Founder & Chief Executive Officer, CaaMTech)Janakan Krishnarajah (Chief Operating Officer and Chief Medical Officer, iX Biopharma)Alexander Speiser (Chief Operating Officer, Orthogonal Thinker)Tracy Cheung, (Chief Communications Officer, COMPASS Pathways)Key companies covered in the report Celon PharmaiX BiopharmaMAPS Public BenefitMindMedJanssen PharmaceuticalsJazz Pharmaceutical For additional details, please visit or email [email protected] You may also be interested in the following titles: Endocannabinoid System Targeted Therapeutics Market, 2020-2030Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive InsightsNeoantigen Targeted Therapies Market, 2019-2030Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics About Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.
In 2019, the Accounting Software Market reached USD 12.03 Bn and is expected to reach USD 19.6 Bn by 2025, at a CAGR of 8 percent over the 2020-2025 estimate period.The accounting software and financial management system industry has undergone many shifts in the last twenty years.One of the main shifts is to deliver accounting software applications focused on the cloud.Accounting software operates internally with various other applications such as CRM, SCM, HRM, and analytical dashboards and reports.Within financial functions such as accounts payable, cash inflows, payroll, and trial balance, accounting solution is used to manage and monitor all such transactions.This software also monitors sales, maintains cash flows, conducts analyses, and produces visualizations and reports.Large businesses and small and medium-sized organizations are widely embracing the best accounting software for tracking financial transactions.Today's leading tools provide visibility of the business in real-time through simple reporting and analytics.
Staff directory management software by Sentrient allows you to maintain and view a comprehensive list of all your employees in one place. Get a free trial today!
Global eClinical Solutions Market is expected to reach US$ XX Bn by 2026 from US$ 4.74 Bn in 2019 at CAGR of XX% (Detailed analysis of the market CAGR is provided in the report).The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters.The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Global eClinical Solutions MarketGlobal eClinical Solutions Market is segmented by product, clinical trial phase, delivery mode, end user, and geography.A web-hosted segment is expected to register the highest growth in the forecast period.The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.Growing adoption of eClinical solutions for improved data standardization is trending the overall Global eClinical Solutions market.The high cost of implementation coupled with the dearth of skilled professionals can pose as a major obstacle for the growth of the eClinical solutions market.Lack of awareness among researchers regarding the advantages of the eClinical solution and less developed infrastructure especially in the developing countries are hindering the eClinical solutions market growth.
PlayStation is undoubtedly the most iconic console for gaming; it has gained huge popularity all around the world and is getting more attention day by day.While you won’t get too many options for those, still, there are some decent ones.We have listed the top 5 PlayStation emulators for Android; let’s have a look at them.ClassicBoyClassicBoy is an excellent emulator that supports a variety of consoles, including Nintendo 64, PlayStation, NeoGeo, NES, and SEGA.This one is also a one-in-all emulator app that provides you with a variety of features, including support for several consoles, decent stability, save and load states, a fast forward mode, support for cheat codes, and hardware support.It is available for free, but it contains ads.ePSXeePSXe is a pretty awesome PlayStation emulator for Android with a straightforward user interface.It even features save and load states, a split-screen mode, support for hardware controllers, customizable controls, as well as OpenGL enhanced graphics.
The app is compatible with most latest game systems, Chromecast, mobile devices, Roku, tablets, and many others.Make sure you check the free version properly before buying its premium version.Google PhotosGoogle Photos is one of the best cloud storage for images.You can create your collection and set them in the background so that your TV looks more gorgeous.You can even get access to the app’s recently launched TV service for $39.99 per month that will offer you more than 50 channels.It offers you a free trial as well; once you try it, you can go for its premium version that will cost you $7.99, $11.99 per month, or $39.99 per month based on what plan you are taking.iHeartRadioiHeartRadio is a fantastic streaming service that operates like Pandora.It is really a great platform for listening to certain types of music, and you can use it for free or even buy its premium version that will cost you $9.99 per month.MediaMonkeyMediaMonkey is an excellent Chromecast app that lets you cast your local music with Chromecast.
Office Setup is the client software of Microsoft consisting of several efficient apps, server apps, and programs.Microsoft Office comes with several subscription plans along with the trial version.An individual can easily opt for the trial version as a free Office subscription, but its services are minimal and time-bound.It is always recommended to choose a paid version because a paid version gives long time benefits with attractive and seamless services.Choosing a subscription plan is not a complicated or annoying task.Users need to visit the site of MS Office at and choose their desired plan.
There are many tools available in the digital world for the migration of PST file to Office 365. but I want to suggest you most Reliable solution that can Import your PST file to Office 365 Account in just few seconds.this Software easily Import your single and multiple PST file to Office 365 account at one time.User can also try this Software free trial version and save 30 emails per folder at free of cost.Get this Software free trial version from here: 
If you are hunting Reliable and Secure Exchange migration software, you have landed in the right place.This article will recommend the best third party migration application.That is EdbMails Exchange migration.This supports all the latest versions of Exchange Server.It can migrate the data from one Exchange server to another Exchange server or to Office 365 server without any data being lost.It meets all the security standards and replicates the data on the target server exactly same as the source server.EdbMails Exchange Migration will perform:• Direct migration of mailboxes from source Exchange server to target Exchange or Office 365 server• Seamless migration of Exchange public folders• Incremental migration ensuring no duplicate items migration to target server• Migration of Archive mailboxes and shared mailboxes• Hosted Exchange migration• Migration of particular mailbox items using filters• Automatic mailbox mapping between source and target serverThe software migrates mailbox of any size.
Blockchain is innovative technology invoked in kinds of activities in business-like, healthcare, insurance, Banks, E-commerce, Supply chain, and FMCG, etc.The venture capital society spilled almost $1 billion into related startups between 2014 and 2016.Blockchain is distributed ledger technology used to record the transaction data with time-stamped.The consumer products companies and retailers seeking a better way of validating supply-chain claims.The banks and insurance companies are interested in verifying the origin of minerals, products about raw materials.Blockchain disrupting Power The Blockchain can be used in power projects, where it is shared distributed ledger technology, power is discrete and concrete, meters can be connected to the blockchain mechanism, wherewith the help of smart contracts power that excessive at a certain place can be shared with other buildings/venues with smart contracts.This is achieved in the real-time application in Brooklyn, New York, a startup called LO3 Energy is using the blockchain to manage clean power trading across a solar-fed microgrid that covers a city block.For example, Brooklyn, New York, where a startup called LO3 Energy is applying the blockchain to manage clean power trading across a solar-fed microgrid that covers a city block filled with both residential buildings and industrial facilities.Each piece of the grid has a blockchain.Groceries and DiamondsBlockchain technology is used for business automation, with the help of a distributed ledger can be aided in tracking the product order and delivery.Walmart is trial-testing a service it developed to observe produce in the United States and pork in China.
Nulavance Cream UK one of the most impressive and viable enemy of maturing arrangement, with the help of this cream treatment, you may effortlessly improve and appealing great facial splendor, perfection.It gives you different advantages, for example, it causes your skin to remain in hydration, likewise improves your skin bluntness, lines, and skin break out issues, this cream keeps your facial sound and most grounded.
Use this NSF to PST Converter Software and easily Migrates Lotus Notes NSF file to Outlook PST without any data loss.It is very proficient and affordable professional software that easily and quickly converts all NSF file of Lotus Notes to usable Outlook PST file within few seconds.You can also use this Software free trial version and where you can save 30 emails per folder at free of cost.You can try this Software free demo version from here: 
NSF to PST Converter is a powerful software that can Convert Lotus Notes NSF file to Outlook PST in just few clicks. this tool efficiently maintains integrity of all items like emails, images, attachments, journals, address books, tasks, appointments, sub folders, folders and notes. This Software easily supports all the version of MS Outlook and Windows OS. Use free demo version and see the original results.Get this Software free trial version from here:    
 To order this 250+ page report, please visit this link Key InclusionsA detailed review of the overall landscape of companies offering contract services for manufacturing of peptides, along with information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), geographical location of CMO, number and location of their respective facilities, type of peptide synthesis method used, type of peptide modification services offered, peptide purification technology used, and regulatory accreditations / certifications.An analysis on the recent developments in the industry, highlighting collaborations, facility expansions, and upcoming peptide synthesis technologies within this domain.Informed estimates of the annual commercial and clinical demand for manufacturing peptides for therapeutic use, based on various relevant parameters, such as target patient population, dosing frequency and dose strength.A clinical trial analysis of completed, and active studies related to peptide therapeutics that are have been / being / likely to be conducted across various geographies, based on the trial registration year, trial phase, trial recruitment status, therapeutic areas type of sponsor / collaborator, geography and number of patients enrolled.An estimate of the overall, installed capacity for manufacturing peptides, based on data reported by industry stakeholders in the public domain; it highlights the distribution of available peptide production capacity across companies of different sizes (small, mid-sized, large and very large firms), scale of operation (clinical and commercial), and key geographical regions (North America, Europe, Asia Pacific).A discussion on regulatory guidelines related to peptide manufacturing, highlighting key differences across various geographies, including the US, Europe, Australia, China, India, Japan and South Korea.It also includes details related to the various challenges, related to regulatory scrutiny, faced by peptide manufacturers.Elaborate profiles of the key players that offer contract manufacturing services across different geographies, namely North America, Europe and Asia Pacific.Each profile features a brief overview of the company, information on its service portfolio, details related to its manufacturing capabilities and facilities, and an informed future outlook.A discussion on industry affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the evolution of this field; it includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on industry dynamics.The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:Scale of OperationCommercialPreclinical / Clinical Type of Peptide Synthesis Method UsedChemicalNon-Chemical Type of Peptide Chemical Synthesis Method UsedLiquid Phase Peptide SynthesisSolid Phase Peptide SynthesisHybrid Phase Peptide Synthesis Type of End UserSmall sized CMOsMid-sized CMOsLarge and very large sized CMOs Key Geographical Region North AmericaEuropeAsia-Pacific and the Rest of the World  To request sample pages, please visit this link Key Questions AnsweredWho are the leading CMOs engaged in peptide API manufacturing?What are the key challenges faced by players engaged in this market?What are the recent developments in this industry?What is the annual, clinical and commercial demand for peptide therapeutics?What is the current, installed manufacturing capacity for peptides?What are the key factors influencing the make (manufacture in-house) versus buy (outsource) decision related to peptide therapeutics?What are the key trends withing the peptide contract manufacturing market?How is the current and future market opportunity likely to be distributed across key market segments?You may also be interested in the following titles:Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030China Biopharmaceutical Contract Manufacturing Market, 2020-2030Antibody Contract Manufacturing Market, 2020 - 2030 Contact UsGaurav Chaudhary+1 (415) 800 [email protected] 
The inherent advantages of peptide therapeutics, such as small size, low immunogenicity and better cellular uptake, has led to a rise in interest in such interventions.This is anticipated to create significant opportunities for CMOs offering peptide manufacturing services.However, in order to meet the current and future demand, contract manufacturers may need to strengthen their respective capabilities and expand available capacities.To order this 250+ page report, which features 100+ figures and 110+ tables, please visit this link The USD 3.2 billion (by 2030) financial opportunity within the peptide therapeutics contract API manufacturing market has been analyzed across the following segments:Scale of OperationClinicalCommercial Type of Peptide Synthesis Method UsedChemicalNon-Chemical Type of Peptide Chemical Synthesis Method UsedLiquid Phase Peptide SynthesisSolid Phase Peptide SynthesisHybrid Phase Peptide Synthesis Company SizeSmallMid-sizedLarge / Very Large Key geographical regionsNorth AmericaEuropeAsia Pacific The Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: AmbioPharmAuspepBachemBCN PeptideChinese PeptideCordenPharmaCPC ScientificCreative PeptidesCSBioHybio PharmaceuticalPEPTIDE INSTITUTEPolyPeptide GroupSenn ChemicalsSinopharm Group Table of Contents  PREFACE  EXECUTIVE SUMMARY  INTRODUCTION  REGULATORY LANDSCAPE  COMPETITIVE LANDSCAPE  COMPANY PROFILES  RECENT DEVELOPMENTS  CLINICAL TRIAL ANALYSIS  REGIONAL CAPABILITY ANALYSIS   DEMAND ANALYSIS  CAPACITY ANALYSIS   MAKE VERSUS BUY DECISION MAKING FRAMEWORK  MARKET SIZING AND OPPORTUNITY ANALYSIS  IMPACT OF THE COVID-19 PANDEMIC ON THE PEPTIDE API CONTRACT MANUFACTURING MARKET  SWOT ANALYSIS  CONCLUSION  SURVEY TRANSCRIPT(S)  APPENDIX 1: TABULATED DATA 19.APPENDIX 2: LIST OF COMPANIES AND ORGANISTIONS To purchase a copy, please visit Contact DetailsGaurav Chaudhary+1 (415) 800 [email protected] 
Roots Analysis has done a detailed study on Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030, covering various important aspects of the industry and identifying key future growth opportunities To order this 250+ page report, which features 100+ figures and 110+ tables, please visit this link Key Market Insights In the past few years, over 1,200 trials, enrolling close to 0.2 million patients suffering from a myriad of disease indications, have been registered globally to evaluate peptide-based drugsCurrently, around 50 companies claim to manufacture peptide-based therapeutics; such players also claim to be capable of providing a variety of additional services to their clientsThe market landscape features the presence of multiple well-established players, most of which claim to operate across all scales of operation, having expertise in more than one method of peptide synthesis and purificationIn order to cater to the growing needs of clients / sponsors, companies have established their presence across different regions; presently, the US, the Netherlands and Switzerland are the hubs for peptide productionContract manufacturers are actively investing in expanding / upgrading existing capabilities and capacity; manufacturing peptide drugs was observed to be the focus of majority of recently inked deals in this domainThe current, installed global manufacturing capacity for peptide therapeutics is estimated to be more than 0.15 million litersPeptide API drug developers are anticipated to continue to outsource their manufacturing operations in the mid to long term, resulting in an annualized growth rate of over 11.2% within the contract service market For more information, please visit Table of Contents  PREFACE1.1.Analysis by Location of Manufacturing Facilities5.2.5.Analysis by Regulatory Accreditations / Certifications 5.3.Scope and Methodology 8.3                   Peptide Therapeutics: Clinical Trial Analysis8.3.1.
According to Healthcare Artificial Intelligence (AI) Market 2020 Global Industry Analysis To 2023, report on “Global Healthcare Artificial Intelligence (AI) Industry” Published by Market Research Future.Healthcare Artificial Intelligence (AI) Market AnalysisAs per a report published by Market Research Future (MRFR), the global healthcare artificial intelligence market is likely to capture an impressive CAGR of 51.9% over the forecast period 2018 to 2023.Technological progress, coupled with the associated algorithm is driving the market growth to a considerable extent.Artificial intelligence (AI) finds wide application in healthcare research activities.The potential of the algorithm to interpret the given data in a meaningful way aids in the manufacturing of precision drugs, predicting the outcome of a medical scenario, and drug discovery.Healthcare Artificial Intelligence (AI) Market SegmentationHealthcare Artificial Intelligence Market has been segmented based on application, component, end user, and technology.By application, the healthcare artificial intelligence market has been segmented into robot-assisted surgery, virtual nursing assistant, clinical trial, dosage error reduction, automated image diagnosis, and preliminary diagnosis.By component, the healthcare artificial intelligence market has been segmented into services, software, and hardware.By end user, the healthcare artificial intelligence market has been segmented into diagnostic centers & hospital, biotechnology & pharmaceutical companies, and research & academic laboratories.By technology, the healthcare artificial intelligence market has been segmented into natural language processing, querying method, and machine learning.Healthcare Artificial Intelligence (AI) Market Regional AnalysisBased on region, the global healthcare AI market has been segmented into Asia-Pacific, Europe, the Americas, and the Middle East and Africa.The Americas held the largest share of the global healthcare AI market.The region is expected to lead the global healthcare AI market in the upcoming years.The growth of the Americas can be attributed to the rapidly expanding biotechnology sector, well-developed healthcare infrastructure, and the progressive instances of robotic surgery.
 Global Electronic Trial Master File (eTMF) Systems Market: By Component (Software, Services), Deployment Mode (Cloud/Web-Based, On-Premise), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others), Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast to 2025Market HighlightsAccording to MRFR analysis, Global eTMF Systems Market is expected to register a CAGR of 13.11% during the forecast period of 2019 to 2025 and anticipated to reach USD 1,825 Million by 2025.The eTMF serves as a central repository to store and manage essential clinical trial documents and content for possible use in regulatory submissions.The eTMF software streamlines agency compliance with standards-based exports, and eSubmissions enables sharing between clinical trial stakeholders with language-independent taxonomy.The growth of the global eTMF systems market is fueled by several factors such as rising activities in terms of acquisitions, new solution and service deployments, and collaborations by key players operating in the market, coupled with the increasing number of clinical trial studies.To provide value to the prospective users, the company has posted its prices and terms online to battle price discrimination in this industry.However, budget constraints of the small and medium-sized enterprises, along with the dearth of skilled professionals for operating the electronic systems, can hinder the preference of such solutions.Such strategies push the growth of the eTMF systems market.Request For Free Sample Copy : AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada.